H-L-Phe-AMC*TFA is an amino acid-derived fluorogenic substrate consisting of L-phenylalanine linked to 7-amino-4-methylcoumarin (AMC) through an amide bond, with the molecule supplied as a TFA (trifluoroacetate) salt. The structure contains a coumarin fluorophore bearing a free aniline-type amino group (AMC), while the phenylalanine portion provides the side-chain benzyl group and the peptide-like carbonyl connectivity, and the TFA counterion is associated with the basic site to form the salt form. In research workflows, this AMC-linked phenylalanine derivative is employed in substrate-based assays and analytical studies where release or generation of the coumarin fluorescence signal is monitored to probe enzyme activity or specificity in peptide-bond hydrolysis contexts.
CAT No: CP25146
CAS No:108321-84-2
Synonyms/Alias:108321-84-2;L-Phenylalanine7-amido-4-methylcoumarintrifluoroacetatesalt;(S)-2-Amino-N-(4-methyl-2-oxo-2H-chromen-7-yl)-3-phenylpropanamide2,2,2-trifluoroacetate;L-Phenylalanine4-methyl-7-coumarinylamidetrifluoroacetatesalt;SCHEMBL380768;78089_FLUKA;MolPort-003-939-037;C19H18N2O3.C2HF3O2;7339AH;AKOS015910343;AK144164;P-3500;I14-40715;L-Phenylalanine7-amido-4-methylcoumarin,trifluoroacetatesalt
Chemical Name:L-Phenylalanine 7-amido-4-methylcoumarin, trifluoroacetate salt, 99%
H-L-Phe-AMC*TFA is a chiral, peptide-derived fluorogenic substrate consisting of L-leucine linked to L-phenylalanine and an aminomethylcoumarin (AMC) reporter, with an AMC-thioester-like activation motif indicated by the AMC*TFA notation and associated trifluoroacetate counterion (TFA). The molecule contains multiple amide linkages that support controlled enzymatic cleavage and a coumarin chromophore that enables sensitive fluorescence readout upon release of the AMC moiety. The stereochemistry at the amino acid centers is defined by the L-configured leucine and phenylalanine residues, which can govern recognition by proteases and peptidase families. The presence of the TFA-associated counterion and the coumarin reporter makes the compound behave as a stable, assay-compatible amino acid-peptide conjugate and a practical biochemical research intermediate for downstream substrate and inhibitor design.
1. Protease Assay Substrates
H-L-Phe-AMC*TFA is used in protease activity screening and biochemical assay development because the L-Leu-L-Phe peptide segment provides a defined recognition motif for peptidases, while the AMC fluorophore enables monitoring of cleavage events by fluorescence. The amide-rich peptide framework participates in enzyme-substrate binding, and the stereochemical identity of the L amino acids can influence catalytic turnover and selectivity across protease classes. The coumarin reporter is positioned to undergo fluorescence generation upon release or transformation of the AMC group, supporting kinetic readouts for substrate specificity studies. Downstream use can include adapting the same scaffold to generate substrate panels for enzyme profiling and to support structure-guided inhibitor optimization in chemical biology workflows.
2. Peptidomimetic SAR Probes
H-L-Phe-AMC*TFA functions as a research probe for structure-activity relationship studies in peptidomimetic design by coupling a short, stereodefined peptide sequence to a measurable AMC reporter. The phenylalanine side chain and the hydrophobic leucine residue provide aromatic and aliphatic interaction handles that can be systematically varied in analog libraries to map binding determinants. The trifluoroacetate association and the activated AMC reporter format can be leveraged to standardize assay conditions when comparing analogs that differ at the peptide recognition elements. The resulting data can be translated into downstream synthesis of modified amino acid derivatives, including N- or C-terminally altered analogs used to refine molecular recognition models.
3. Enzyme Inhibitor Discovery
H-L-Phe-AMC*TFA supports enzyme inhibitor discovery campaigns by serving as a competitive or noncompetitive screening substrate for protease targets where cleavage of the Leu-Phe linkage generates an AMC fluorescence signal. The defined L-configuration at both amino acid residues helps align the substrate conformation with enzyme active-site geometry, improving interpretability when comparing inhibitor chemotypes. The peptide-to-reporter architecture enables rapid discrimination between compounds that interfere with substrate binding and those that affect catalytic processing, facilitating medicinal chemistry iteration. Downstream derivative formation can include conversion of the recognition motif into inhibitor scaffolds, including peptidomimetic electrophiles or non-cleavable analogs that preserve key side-chain features while modulating reactivity.
4. Fluorogenic Peptide Standards
H-L-Phe-AMC*TFA is suitable for analytical research and method development where fluorogenic peptide standards are required to calibrate fluorescence response and validate assay signal generation. The coumarin reporter provides a direct optical handle, while the peptide backbone and stereochemical amino acid composition help ensure consistent cleavage behavior relative to related substrates. The presence of the TFA counterion can support reproducible solubility and handling in assay-relevant media, which is important for comparing batch-to-batch performance in research settings. The compound can also serve as a reference material for developing LC/fluorescence-compatible analytical workflows aimed at monitoring peptide substrate integrity and cleavage products.
5. Industrial Process Chemistry Intermediate
H-L-Phe-AMC*TFA can be employed in specialty chemical production and process chemistry intermediate preparation for coumarin-based fluorogenic reagents used in industrial enzyme monitoring and bioprocess analytics. The molecule's structured peptide segment and AMC reporter enable downstream manufacturing routes to related activated amino acid derivatives, including reporter-bearing peptide fragments and substrate analogs for protease control. The defined stereochemistry at the amino acid centers supports reproducible performance when scaling synthesis of structurally related assay reagents. The trifluoroacetate association provides a practical handle for salt formation and formulation during reagent manufacturing, supporting consistent downstream use in industrial analytical applications.
3. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
5. Cationic cell-penetrating peptides are potent furin inhibitors
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.